Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of mirtazapine tablets 30mg in China. Welcome to wholesale bulk high quality mirtazapine tablets 30mg for sale here from our factory. Good service and reasonable price are available.
Mirtazapine Tablets 30mg is an oral antidepressant medication that belongs to the tetracyclic antidepressants (TeCA) and is classified as both noradrenergic and specific serotonergic antidepressants (NaSSA). Its core component, mirtazapine, exerts therapeutic effects through multiple neurotransmitter regulatory mechanisms. The alpha ₂ receptor antagonizes and blocks the central presynaptic membrane alpha ₂ receptors, relieving negative feedback inhibition on the release of norepinephrine (NE) and serotonin (5-HT), thereby enhancing adrenergic and serum neurotransmission. This mechanism directly increases the concentration of NE and 5-HT in the brain, improving symptoms of low mood and lack of motivation. It can be combined with patients with sleep disorders or decreased appetite (due to H ₁ receptor antagonism). Needs individuals with minimal impact on sexual function (compared to SSRIs, the incidence of sexual dysfunction is reduced by 40%). It is recommended to continue taking the medication for 4-6 months until the symptoms completely disappear. Sudden discontinuation of medication may lead to rebound symptoms.
Our product
 |
 |
 |
 |
Mirtazapine COA
The Polycrystalline Phenomenon of Mirtazapine: The Magic and Challenges of Homogeneous Anomalies
In the field of drug development, the phenomenon of multiple crystal structures formed by the same molecule under different crystallization conditions, known as polymorphs, has always been a core variable affecting drug performance. Taking the antidepressant Mirtazapine Tablets 30mg as an example, its molecular formula is C17H19N3, but by changing the solvent, temperature, or crystallization process, significantly different crystal forms can be formed. The differences in solubility, dissolution rate, stability, and bioavailability of these crystal forms may directly determine the clinical efficacy and safety of drugs:
Molecular Code of Mirtazapine: A "Neural Regulatory Network" with a Four Ring Structure
Mirtazapine belongs to the tetracyclic piperazine pyridine derivative, and its molecular structure achieves a synergistic effect of antidepressant and sleep aid through a dual mechanism of action:
Norepinephrine system enhancement
As a presynaptic α ₂ receptor antagonist, mirtazapine blocks the negative feedback inhibition of NE release by its own receptors, enhances the activity of locus coeruleus (LC) neurons, shortens the latency to sleep, and reduces nighttime awakenings. The experiment showed that at a dose of 5mg/kg, the spontaneous discharge activity of NA neurons in the locus coeruleus of rats was significantly increased.
Serotonin can regulate the system
By antagonizing 5-HT ₂ C receptors, mirtazapine relieves its inhibition of DA and NE release; Simultaneously blocking 5-HT receptor and reducing chemotherapy-induced nausea and vomiting. In vivo studies have confirmed that it can dose dependently enhance the firing activity of 5-HT neurons.
Histamine system sedation
Its strong antagonistic effect on H ₁ receptors gives it a benzodiazepine like sedative effect, but without addictive properties. Clinical data shows that a dose of 15mg/day can shorten the time for patients to fall asleep by 22 minutes and prolong the total sleep time by 1.1 hours.
This multi-target mechanism of action makes mirtazapine one of the preferred drugs for treating depression combined with insomnia, but its flexible molecular structure also provides a physical basis for the formation of polymorphs.
Molecular ballet of polymorphic phenomena: dynamic balance between conformation and stacking
The polymorphic phenomenon of Mirtazapine Tablets 30mg is due to the flexibility of its molecular conformation and the diversity of intermolecular forces. According to crystallographic classification, its polymorphs can be divided into conformational polymorphs and conformational polymorphs:
Conformational polymorph: The flexible twisting of the molecular skeleton leads to a change in the stacking mode. For example, in solvent diffusion crystallization, the π - π interaction distance between the benzene rings of mirtazapine molecules is shortened from 3.6 Å to 3.35 Å, forming a tighter lattice structure and leading to a decrease in solubility.
Polycrystalline configuration: Fine tuning of molecular chiral centers leads to stacking differences. The left-handed enantiomer (S-enantiomer) of mirtazapine preferentially blocks alpha ₂ and 5-HT ₂ receptors, while the right-handed enantiomer (R-enantiomer) specifically blocks 5-HT ∝ receptors. This structural difference may be reflected by differences in the symmetry of molecular arrangement in the lattice.
Formation mechanism:
Solvent effect: In DMSO, mirtazapine forms a metastable crystal form due to the participation of solvent molecules in hydrogen bonding networks, and its dissolution rate is 40% higher than that of ethanol crystallization products.
Temperature gradient: In programmed cooling crystallization, heat treatment above 75 ℃ can transform crystal form II into a more stable crystal form I, with the melting point increasing from 168 ℃ to 172 ℃.
Mechanical action: Ball milling treatment leads to lattice defects, increasing the amorphous content from 5% to 18%, significantly affecting the compression performance.
The "performance map" of polymorphic forms: a leap from laboratory to clinical practice
The differences in physicochemical properties of different crystal forms directly determine the development strategy of mirtazapine formulations:
Solubility and dissolution rate: the key to bioavailability:
Crystal form A (metastable state): The solubility reaches 0.8mg/mL in pH 6.8 buffer solution, and the dissolution rate constant (k) is 0.12min ⁻¹. The AUC ₀₋₂₄ h in beagle dogs is 2.6 times higher than that of crystal form B.
Crystal form B (stable state): The solubility is only 0.4mg/mL, but the chemical stability is excellent. After being stored at 40 ℃/75% RH for 6 months, the increase in related substances is less than 0.3%.
Clinical significance: For BCS class II (low solubility high permeability) drug mirtazapine, selecting a metastable crystal form can significantly improve oral bioavailability, but the risk of crystal transformation needs to be controlled through micronization technology (d ₉₀<25 μ m) and coating process.
Moisture absorption and stability:
The "invisible threshold" of formulation technology: Half hydrate crystal form: In a 75% RH environment, it absorbs moisture and increases weight by 8% within 24 hours, transforming into dihydrate and causing the formulation to clump.
Anhydrous crystal form: hygroscopic weight gain<1%, but it is necessary to control the residual crystallization solvent (DMSO<500ppm), otherwise it may induce crystal transformation.
Process control: Freeze drying method is used to prepare amorphous mirtazapine, which can completely avoid the formation of hydrates, but the pre freezing temperature (-45 ℃) and sublimation rate (0.5 ℃/min) need to be optimized to prevent glass transition.
Powder properties: the "physical basis" of formulation production:
Crystal form C (needle shaped): with a resting angle of 45 ° and poor fluidity, it needs to be improved by adding 2% silica.
Crystal form D (block): angle of repose 28 °, can be directly used for dry granulation, but has poor compressibility (elastic recovery rate>15%).
Solution: prepare spherical particles (d ₀=50 μ m) by spray drying, so that the fluidity (Karl index<18%) and compressibility (compressibility<25%) meet the standard at the same time.
Polycrystalline 'Research Toolbox': From Structural Analysis to Process Control
Single crystal X-ray diffraction (SXRD) reveals the existence of N-H ··· O=C hydrogen bonding network between molecules in crystal form A, with a lattice energy 12 kJ/mol lower than that of crystal form B, explaining its higher solubility.
Powder X-ray diffraction (PXRD): Establish a characteristic peak library for crystal form A (2 θ=12.4 °, 19.7 °, 24.1 °) with a detection limit of 0.1%, used for batch consistency control of raw materials.
Differential Scanning Calorimetry (DSC): Crystal form A exhibits an endothermic peak (melting) at 162 ℃, while crystal form B exhibits an exothermic peak (crystallization) at 170 ℃, allowing for quantitative analysis of the mixed crystal ratio.
Thermogravimetric analysis (TGA): Detect 0.8% of crystal water in crystal form C, set the drying temperature to<80 ℃ to avoid dehydration and crystal transformation.
Raman spectroscopy: Crystal A exhibits a strong peak of C=O stretching vibration at 1640cm ⁻¹, while crystal B shows a red shift of this peak to 1625cm ⁻¹, which is used for real-time monitoring of process analysis technology (PAT).
Solid state nuclear magnetic resonance (ssNMR): Distinguishing local motion differences of molecular chains in crystal forms and explaining differences in dissolution rates.
The 'development challenge' of polymorphs: balancing techniques from laboratory to market
Patent barriers and generic drug development
The original drug Mirtazapine Tablets 30mg have extended their market monopoly period through the patented crystal form B. Generic drug companies need to develop non infringing crystal forms:
Crystal form E (eutectic): forms a 1:1 eutectic with succinic acid, increasing solubility by three times, but it needs to be proven to be bioequivalence with the original crystal form.
Undefined form: prepared by HME (hot melt extrusion) technology, bypassing the crystal form patent, but requiring stability issues (crystallinity<5% after 6 months).
Polycrystalline transformation may cause fluctuations in therapeutic efficacy:
Case: A generic drug company was forced to recall its products due to an increase in nighttime awakenings of patients caused by failure to control the content of crystal form A (>15%).
Solution: Establish a fast detection method based on PXRD to control the impurity of crystal form A within<3%.
Production process optimization
Continuous crystallization process can improve the reproducibility of crystal structure:
Comparative data: The content of crystal form B fluctuates by ± 8% between traditional intermittent crystallization batches, while the fluctuation of continuous crystallization process drops to ± 2%.
Equipment selection: Adopting a mixed suspension mixed discharge (MSMPR) crystallizer, the crystal proportion is precisely controlled by adjusting the residence time (15-30 minutes).
Mirtazapine tablets are a valuable therapeutic option for managing depression and anxiety, offering a unique mechanism of action and a favorable side effect profile in certain patient populations. By understanding its pharmacokinetics, therapeutic uses, efficacy, and safety profile, healthcare providers can optimize the use of mirtazapine to improve patient outcomes. However, careful monitoring and adherence to dosing guidelines are essential to minimize the risk of side effects and drug interactions. As with any medication, patients should be encouraged to communicate openly with their healthcare providers about their symptoms, concerns, and treatment preferences to ensure the best possible care.
Frequently Asked Questions
Is mirtazapine the same as Xanax?
+
-
Is mirtazapine the same as Xanax? Xanax and mirtazapine are two entirely different drugs. Mirtazapine is a tetracyclic antidepressant used to treat major depressive disorder, while Xanax is a benzodiazepine used primarily to treat anxiety and panic disorder.
Who needs mirtazapine?
+
-
Why is this medication prescribed? Mirtazapine is used to treat depression. Mirtazapine is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain to maintain mental balance.
What is an alternative to mirtazapine for sleep?
+
-
"Common alternatives to Mirtazapine for the treatment of anxiety and depression include Escitalopram and Fluoxetine. Trazodone is a common alternative used for sleep. Trazodone is especially used for patients who desire improved sleep without Mirtazapine's possible side effect of weight gain."
What are the benefits of taking mirtazapine?
+
-
Mirtazapine is an antidepressant medicine. It's used to treat depression and sometimes obsessive compulsive disorder (OCD) and anxiety. It works by increasing the amount of mood-enhancing chemicals called noradrenaline and serotonin in your brain.
Why is mirtazapine so hard to come off?
+
-
Because mirtazapine alters levels of brain chemicals that regulate mood, when a person stops taking mirtazapine, the body will need time to adjust. For this reason, gradually tapering off the drug can help relieve many withdrawal symptoms.
Hot Tags: mirtazapine tablets 30mg, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale